Director Medical Value – Evidence – And Outcomes
| Company | Arrowhead Pharmaceuticals |
|---|---|
| Location | Pasadena, CA, USA |
| Salary | $210000 – $240000 |
| Type | Full-Time |
| Degrees | Master’s, PharmD, PhD, MD |
| Experience Level | Senior |
Requirements
- Advanced degree in health economics, health outcomes research, or a related field (MSc, MPH, PhD, PharmD, MD)
- At least five years of relevant experience in health economics, outcomes research, pricing, reimbursement, medical affairs, and/or portfolio analysis
- Experience in cardiometabolic therapeutic area, preferably with a focus on dyslipidemias
- Ability to clearly communicate complex scientific and medical concepts, both written and orally; detail-oriented and data-driven
- Ensure compliance with corporate policies, procedures, and US healthcare laws and regulations
- Ability to work collaboratively in a matrixed, team-based environment, with strong organizational and time management capabilities
- Exceptional project management skills, ensuring on-time and budget-compliant deliverables
- Passionate in working in a fast-paced, team-based environment
Responsibilities
- Develop and execute the Real World Evidence (RWE) generation strategy for Arrowhead’s cardiometabolic pipeline to inform value proposition from both a medical and payer perspective
- Develop and review economic resources, including cost-effectiveness models, to support value proposition. Integrate research findings into payer communication materials
- Develop publications and external communications based on real world evidence generation, partnering closely with the publications lead
- Educate payers by delivering impactful scientific and economic data presentations
- Collaborate with commercial team members to align payer positioning and messaging with outcome-based evidence. Share expertise as a trusted partner and resource
- Effectively manage consultants and vendors
- Review clinical development plans, including trial design, endpoints, and analytical strategies, to provide feedback and ensure alignment with payer needs
- Attend medical, pharmacy, and payer professional meetings to stay current and ensure expertise with industry trends and new research affecting Familial Chylomicronemia Syndrome (FCS), Severe Hypertriglyceridemia (SHTG), and Mixed Hyperlipidemia
- Conduct horizon scanning and maintain literature awareness to identify and evaluate scientific gaps and opportunities in the cardiometabolic space
- Stay informed about current advancements and new developments in RNA interference
Preferred Qualifications
-
No preferred qualifications provided.